专利号:US-6451543-B1 优先权日:1998-08-31 标题:Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides 发明人:KOCHENDOERFER GERD G; HUNTER CHRISTIE L; KENT STEPHEN B H; BOTTI PAOLO 权利人:GRYPHON SCIENCES 摘要:The present invention relates to methods and compositions for lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides that are incorporated in a lipid matrix. The invention is exemplified in production of a prefolded membrane polypeptide embedded within a lipid matrix via stepwise chemoselective chemical ligation of unprotected peptide segments, where at least one peptide segment is embedded in a lipid matrix. Any chemoselective reaction chemistry amenable for ligation of unprotected peptide segments can be employed. Suitable lipid matrices include liposomes, micelles, cell membrane patches and optically isotropic cubic lipidic phase matrices. Prefolded synthetic and semi-synthetic membrane polypeptides synthesized according to the methods and compositions of the invention also permit site-specific incorporation of one or more detectable moieties, such as a chromophore, which can be conveniently introduced during synthesis. The methods and compositions of the invention have multiple uses. For example, they can be used to assay ligand binding to membrane polypeptides and domains comprising a receptor, and thus are extremely useful for structure/function studies, drug screening/selection/design, and diagnostics and the like, including high-throughput applications. The methods and compositions of the invention are particularly suited for FRET analyses of previously inaccessible membrane polypeptides.
专利号:US-5405949-A 优先权日:1993-03-29 标题 :Process for the synthesis of glycosaminoglycans with heparin or heparan structure modified in position 2 of the α-L-iduronic-2-O-sulfate acid 发明人:UNGARELLI FABRIZIO; PIANI SILVANO 权利人:ALFA WASSERMANN SPA 摘要:A process for the synthesis of glycosaminoglycans with heparin or heparan structure modified in position 2 of the α-L-iduronic-2-O-sulfate acid in which the sulfate group is, entirely or in part, substituted with a nucleophilic group, is described. The process is carried out by treating glycosaminoglycans having heparin or heparan structure with a nucleophilic reagent in alkaline solution.
专利号:US-5410039-A 优先权日:1993-03-29 标题 :Process for the synthesis of glycosaminoglycans containing α-L-galacturonic acid substituted with nucleophilic groups in position 3 发明人:UNGARELLI FABRIZIO; PIANI SILVANO 权利人:ALFA WASSERMANN SPA 摘要:A process for the synthesis of glycosaminoglycans in which one of the α-L-iduronic-2-O-sulfate acid saccharide units, which is characteristic of glycosaminoglycans with heparin or heparan structure, has undergone a structural modification, entirely or in part, with transformation into α-L-galacturonic acid substituted in position 3 with nucleophilic groups, is described. The process is carried out by treating glycosaminoglycans having heparin or heparan structure with a nucleophilic reagent in alkaline solution.
专利号:WO-2023227913-A1 优先权日:2022-05-27 标 题:Creating nucleic acids for in-vitro protein synthesis 发明人:CHEN MICHAEL CHUN HAO; MCINROY GORDON ROSS; OST TOBIAS WILLIAM BARR 权利人:NUCLERA LTD 摘要:Provided herein are methods, and compositions for the synthesis of genes and proteins. The methods are applicable to synthesis of nucleic acids and proteins on a microfluidic device.
专利号:US-2004033532-A1 优先权日:2002-08-08 标题 :Use of three-dimensional crystal structure coordinates to design and synthesize domain-selective inhibitors for angiotensin-converting enzyme (ACE) 发明人:EHLERS MARIO R W; HOLMQUIST BARTON 摘要:It has now been discovered that the use of the three-dimensional crystal structure coordinates of angiotensin-converting enzyme (ACE) will enable the design and synthesis, by means of computational chemistry and structure-guided drug design, of inhibitors of ACE that are highly selective and specific for either the N domain or the C domain of the enzyme, for the treatment of diverse diseases. The invention also relates to methods and processes for the structure-guided design and synthesis of dual N- and C-domain ACE inhibitors, and inhibitors that operate by competitive, non-competitive, uncompetitive, and irreversible mechanisms.
专利号:US-5219741-A 优先权日:1989-09-06 标题:Method of making L-proline using an N-acyl-L-protine acylase 发明人:GROEGER ULRICH; LEUCHTENBERGER WOLFGANG; DRAUZ KARLHEINZ 权利人:DEGUSSA 摘要:A microbiologically produced, thermostable N-acylproline-acylase and a process for obtaining it from Comamonas testosteroni DSM 5416 and Alcaligenes denitrificans DSM 5417. The enzyme is useful for the synthesis of L-proline from various N-acyl-L-proline derivatives.
摘要:S. P. Datta and B. R. Rabin. Trans. Faraday Soc. 52, 1117 (1956). 参考文献:10.1021/jm0511029 摘要:Vig BS, Stouch TR, Timoszyk JK, Quan Y, Wall DA, Smith RL, Faria TN. Human PEPT1 pharmacophore distinguishes between dipeptide transport and binding. J Med Chem. 2006 Jun 15;49(12):3636–44. doi: 10.1021/jm0511029. 参考文献:10.1016/j.bbrc.2006.05.175 摘要:Gilmore BF, Lynas JF, Scott CJ, McGoohan C, Martin L, Walker B. Dipeptide proline diphenyl phosphonates are potent, irreversible inhibitors of seprase (FAPα). Biochemical and Biophysical Research Communications. 2006 Jul;346(2):436–46. doi: 10.1016/j.bbrc.2006.05.175. 参考文献:10.1021/ja711021m 摘要:Dai N, Wang XJ, Etzkorn FA. The effect of a trans-locked Gly-Pro alkene isostere on collagen triple helix stability. J Am Chem Soc. 2008 Apr 23;130(16):5396–7. doi: 10.1021/ja711021m.